Oxford, UK: Biotech start-up, DJS Antibodies, is the second company to move into the newly converted class II laboratory space at The Oxford Trust’s Wood Centre for Innovation.

DJS Antibodies, which will join recently announced Samsara Therapeutics, was founded in 2015 by David Llewellyn and Joe Illingworth who met while studying at the University of Oxford’s Jenner Institute.

For more information click here.